146 related articles for article (PubMed ID: 6347474)
21. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
Suzuki M
Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
[TBL] [Abstract][Full Text] [Related]
23. T cell helper defect in patients with chronic lymphocytic leukemia.
Chiorazzi N; Fu SM; Montazeri G; Kunkel HG; Rai K; Gee T
J Immunol; 1979 Mar; 122(3):1087-90. PubMed ID: 376702
[TBL] [Abstract][Full Text] [Related]
24. Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset.
Thomas Y; Rogozinski L; Irigoyen OH; Shen HH; Talle MA; Goldstein G; Chess L
J Immunol; 1982 Mar; 128(3):1386-90. PubMed ID: 6460060
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
[TBL] [Abstract][Full Text] [Related]
26. Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation.
Strong DM; Pandolfi F; Slease RB; Budd JE; Woody JN
J Immunol; 1981 Jun; 126(6):2205-8. PubMed ID: 6453158
[TBL] [Abstract][Full Text] [Related]
27. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type.
Herrmann F; Lochner A; Philippen H; Jauer B; Rühl H
Clin Exp Immunol; 1982 Jul; 49(1):157-62. PubMed ID: 6982129
[TBL] [Abstract][Full Text] [Related]
28. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
29. T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study.
Semenzato G; Pezzutto A; Agostini C; Albertin M; Gasparotto G
Cancer; 1981 Nov; 48(10):2191-7. PubMed ID: 6457682
[TBL] [Abstract][Full Text] [Related]
30. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.
Faguet GB
J Clin Invest; 1979 Jan; 63(1):67-74. PubMed ID: 153914
[TBL] [Abstract][Full Text] [Related]
32. [Chronic T-cell lymphoid leukemia with helper cell phenotype].
Merson AG; Gipsh NM; Shif BA; Sochnev AM; Poluéktova LE
Eksp Onkol; 1984; 6(4):41-3. PubMed ID: 6238817
[TBL] [Abstract][Full Text] [Related]
33. Comparison of different markers on blood lymphocytes of chronic lymphocytic leukemia.
Götze D; Fiebig H; Mansfeld HW; Mey U; Schön E; Uhle R; Ansorge S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):233-40. PubMed ID: 2410330
[TBL] [Abstract][Full Text] [Related]
34. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
35. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
36. An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subset.
Moss VE; Miedema F; Matutes E; Terpstra F; Brownell A; Brozovic M; Catovsky D
Clin Exp Immunol; 1986 Feb; 63(2):303-11. PubMed ID: 3486061
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
38. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
Yamada S; Miyagawa Y; Komiyama A; Akabane T
Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
[TBL] [Abstract][Full Text] [Related]
39. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers.
Hughes DA; Haslam PL; Townsend PJ; Turner-Warwick M
Clin Exp Immunol; 1985 Aug; 61(2):459-66. PubMed ID: 2931227
[TBL] [Abstract][Full Text] [Related]
40. B-cell function in patients with chronic lymphocytic leukemia.
Sieber G; Herrmann F; Enders B; Rühl H
Klin Wochenschr; 1982 Oct; 60(20):1303-9. PubMed ID: 6755054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
